Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281569644> ?p ?o ?g. }
- W4281569644 endingPage "e004297" @default.
- W4281569644 startingPage "e004297" @default.
- W4281569644 abstract "Immunotherapy for hepatocellular carcinoma (HCC) exhibits limited clinical efficacy due to immunosuppressive tumor microenvironment (TME). Tumor-infiltrating macrophages (TIMs) account for the major component in the TME, and the dominance of M2 phenotype over M1 phenotype in the TIMs plays the pivotal role in sustaining the immunosuppressive character. We thus investigate the effect of bufalin on promoting TIMs polarization toward M1 phenotype to improve HCC immunotherapy.The impact of bufalin on evoking antitumor immune response was evaluated in the immunocompetent mouse HCC model. The expression profiling of macrophage-associated genes, surface markers and cytokines on bufalin treatment in vitro and in vivo were detected using flow cytometry, immunofluorescence, western blot analysis, ELISA and RT-qPCR. Cell signaling involved in M1 macrophage polarization was identified via the analysis of gene sequencing, and bufalin-governed target was explored by immunoprecipitation, western blot analysis and gain-and-loss of antitumor immune response. The combination of bufalin and antiprogrammed cell death protein 1 (anti-PD-1) antibody was also assessed in orthotopic HCC mouse model.In this study, we showed that bufalin can function as an antitumor immune modulator that governs the polarization of TIMs from tumor-promoting M2 toward tumor-inhibitory M1, which induces HCC suppression through the activation of effector T cell immune response. Mechanistically, bufalin inhibits overexpression of p50 nuclear factor kappa B (NF-κB) factor, leading to the predominance of p65-p50 heterodimers over p50 homodimers in the nuclei. The accumulation of p65-p50 heterodimers activates NF-κB signaling, which is responsible for the production of immunostimulatory cytokines, thus resulting in the activation of antitumor T cell immune response. Moreover, bufalin enhances the antitumor activity of anti-PD-1 antibody, and the combination exerts synergistic effect on HCC suppression.These data expound a novel antitumor mechanism of bufalin, and facilitate exploitation of a new potential macrophage-based HCC immunotherapeutic modality." @default.
- W4281569644 created "2022-05-27" @default.
- W4281569644 creator A5004086293 @default.
- W4281569644 creator A5021958897 @default.
- W4281569644 creator A5026178309 @default.
- W4281569644 creator A5030434545 @default.
- W4281569644 creator A5031774464 @default.
- W4281569644 creator A5037050291 @default.
- W4281569644 creator A5044367029 @default.
- W4281569644 creator A5047258558 @default.
- W4281569644 creator A5051223797 @default.
- W4281569644 creator A5052249335 @default.
- W4281569644 creator A5053985637 @default.
- W4281569644 creator A5059071043 @default.
- W4281569644 creator A5068382717 @default.
- W4281569644 creator A5073692772 @default.
- W4281569644 creator A5081976284 @default.
- W4281569644 creator A5089698058 @default.
- W4281569644 date "2022-05-01" @default.
- W4281569644 modified "2023-10-01" @default.
- W4281569644 title "Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma" @default.
- W4281569644 cites W1586859443 @default.
- W4281569644 cites W1990788258 @default.
- W4281569644 cites W2010453472 @default.
- W4281569644 cites W2018527946 @default.
- W4281569644 cites W2020436718 @default.
- W4281569644 cites W2025381786 @default.
- W4281569644 cites W2046056065 @default.
- W4281569644 cites W2051044253 @default.
- W4281569644 cites W2061123122 @default.
- W4281569644 cites W2066671159 @default.
- W4281569644 cites W2067817634 @default.
- W4281569644 cites W2070855360 @default.
- W4281569644 cites W2074150439 @default.
- W4281569644 cites W2078490888 @default.
- W4281569644 cites W2082263327 @default.
- W4281569644 cites W2098236252 @default.
- W4281569644 cites W2105724560 @default.
- W4281569644 cites W2115185894 @default.
- W4281569644 cites W2119305519 @default.
- W4281569644 cites W2123105952 @default.
- W4281569644 cites W2137257146 @default.
- W4281569644 cites W2142492088 @default.
- W4281569644 cites W2159560463 @default.
- W4281569644 cites W2335925695 @default.
- W4281569644 cites W2560367415 @default.
- W4281569644 cites W2582686270 @default.
- W4281569644 cites W2755693293 @default.
- W4281569644 cites W2794322048 @default.
- W4281569644 cites W2795334950 @default.
- W4281569644 cites W2801309958 @default.
- W4281569644 cites W2886864635 @default.
- W4281569644 cites W2889091651 @default.
- W4281569644 cites W2944630124 @default.
- W4281569644 cites W2945755907 @default.
- W4281569644 cites W2970486139 @default.
- W4281569644 cites W2983069092 @default.
- W4281569644 cites W2987385271 @default.
- W4281569644 cites W2999417355 @default.
- W4281569644 cites W3040461816 @default.
- W4281569644 cites W3048102544 @default.
- W4281569644 cites W3111053993 @default.
- W4281569644 cites W3135107870 @default.
- W4281569644 cites W4210955410 @default.
- W4281569644 doi "https://doi.org/10.1136/jitc-2021-004297" @default.
- W4281569644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35618286" @default.
- W4281569644 hasPublicationYear "2022" @default.
- W4281569644 type Work @default.
- W4281569644 citedByCount "22" @default.
- W4281569644 countsByYear W42815696442022 @default.
- W4281569644 countsByYear W42815696442023 @default.
- W4281569644 crossrefType "journal-article" @default.
- W4281569644 hasAuthorship W4281569644A5004086293 @default.
- W4281569644 hasAuthorship W4281569644A5021958897 @default.
- W4281569644 hasAuthorship W4281569644A5026178309 @default.
- W4281569644 hasAuthorship W4281569644A5030434545 @default.
- W4281569644 hasAuthorship W4281569644A5031774464 @default.
- W4281569644 hasAuthorship W4281569644A5037050291 @default.
- W4281569644 hasAuthorship W4281569644A5044367029 @default.
- W4281569644 hasAuthorship W4281569644A5047258558 @default.
- W4281569644 hasAuthorship W4281569644A5051223797 @default.
- W4281569644 hasAuthorship W4281569644A5052249335 @default.
- W4281569644 hasAuthorship W4281569644A5053985637 @default.
- W4281569644 hasAuthorship W4281569644A5059071043 @default.
- W4281569644 hasAuthorship W4281569644A5068382717 @default.
- W4281569644 hasAuthorship W4281569644A5073692772 @default.
- W4281569644 hasAuthorship W4281569644A5081976284 @default.
- W4281569644 hasAuthorship W4281569644A5089698058 @default.
- W4281569644 hasBestOaLocation W42815696441 @default.
- W4281569644 hasConcept C104317684 @default.
- W4281569644 hasConcept C190283241 @default.
- W4281569644 hasConcept C202751555 @default.
- W4281569644 hasConcept C203014093 @default.
- W4281569644 hasConcept C2776107976 @default.
- W4281569644 hasConcept C2776415932 @default.
- W4281569644 hasConcept C2776682551 @default.
- W4281569644 hasConcept C2777151579 @default.
- W4281569644 hasConcept C2777701055 @default.